[ad_1]
Johnson & Johnson’s stock seesawed into the red in early trading Wednesday, after the drugmaker beat second-quarter profit expectations but lowered its full-year outlook.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...